Evidence map›Paper›PMID 31796850›Full record

ArticleScientific reports2019

Neurite regrowth stimulation by a red-light spot focused on the neuronal cell soma following blue light-induced retraction.

Yu-Chiu Kao, Yu-Cing Liao, Pei-Lin Cheng, Chau-Hwang Lee

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Control of actin polymerizationFrontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Chiu KaoResearch Center for Applied Sciences, Academia Sinica, Taipei, 11529, Taiwan.
Yu-Cing LiaoInstitute of Biophotonics, National Yang-Ming University, Taipei, 11221, Taiwan.
Pei-Lin ChengInstitute of Molecular Biology, Academia Sinica, Taipei, 11529, Taiwan.ORCID http://orcid.org/0000-0002-0090-8153
Chau-Hwang LeeResearch Center for Applied Sciences, Academia Sinica, Taipei, 11529, Taiwan. clee@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0001-5013-7062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction of light with biological tissues has been considered for various therapeutic applications. Light-induced neurite growth has the potential to be a clinically useful technique for neuron repair. However, most previous studies used either a large illumination area to accelerate overall neurite growth or employed a light spot to guide a growing neurite. It is not clear if optical stimulation can induce the regrowth of a retracted neurite. In the present work, we used blue light (wavelength: 473 nm) to cause neurite retraction, and we proved that using a red-light (wavelength: 650 nm) spot to illuminate the soma near the junction of the retracted neurite could induce neurite regrowth. As a comparison, we found that green light (wavelength 550 nm) had a 62% probability of inducing neurite regrowth, while red light had a 75% probability of inducing neurite regrowth at the same power level. Furthermore, the neurite regrowth length induced by red light was increased by the pre-treatment with inhibitors of myosin functions. We also observed actin propagation from the soma to the tip of the re-growing neurite following red-light stimulation of the soma. The red light-induced extension and regrowth were abrogated in the calcium-free medium. These results suggest that illumination with a red-light spot on the soma may trigger the regrowth of a neurite after the retraction caused by blue-light illumination.

Indexed as

LightActinsAnimalsCalciumCell Line, TumorColorCulture MediaHeterocyclic Compounds, 4 or More RingsHippocampusLow-Level Light TherapyMiceMyosin Type IINerve RegenerationNeuritesPrimary Cell CultureRatsActinsblebbistatinCalciumCulture MediaHeterocyclic Compounds, 4 or More RingsMyosin Type II

Identifiers

PMID31796850
PMCPMC6890775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.